ClinicalTrials.gg
Drug

Ramelteon clinical trials

Also written Rozerem, TAK-375 and TAK-375SL.

studies test it
66
open now
3
in phase 3
18
first study started
2002

How each study uses ramelteon is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ramelteon studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Jul 2005 · ROZEREM · NDA 021782 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ramelteon
55
Ramelteon 8mg
3
Rozerem (Ramelteon)
3
Ramelteon 8 mg
2

Brand

Rozerem
48
Rozerem 8mg
1

Development codes

TAK-375
20
TAK-375SL
2

Studies by the year they started

66 studies that test it; most in 2007 (13)

Studies that test ramelteon, by start year
YearStudies
20023
20033
20055
20068
200713
200810
20093
20101
20122
20151
20162
20175
20182
20192
20201
20221
20231
20242
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
9
Phase 3
18
Phase 4
29
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 43

Takeda (22) · Massachusetts General Hospital (3) · University of Pennsylvania (2) · Johns Hopkins University (2) · Lehigh Valley Hospital (2) · Southern California Institute for Research and Education (2) · Brigham and Women's Hospital (2) · Northwestern University (2)

Often tested with

Tested in the same studies.

Zolpidem (2) · Doxepin (2) · Risperidone (1) · Haloperidol (1) · Eszopiclone (1) · Gabapentin (1) · Zopiclone (1) · Escitalopram (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test ramelteon, phase 3 first.

Studies

Open first, then newest update. How each study uses ramelteon is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 66

See all 66 studies that test ramelteon →

As the comparator · 2 — what is tested is compared with ramelteon

Codes

What other systems call ramelteon · ClinicalTrials.gg INT004738

  • MeSH (NLM) C495910ramelteonOne source NLM
  • UNII (FDA) 901AS54I69RAMELTEONConfirmed FDA, NLM, Wikidata
  • RxNorm 596205Confirmed FDA, Wikidata
  • Wikidata Q417689ramelteonConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66504RamelteonOne source FDA
  • DrugBank DB00980One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.